PAS
ABBV icon

PKS Advisory Services’s AbbVie ABBV Stock Holding History

PKS Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$775K Buy
3,568
+85
+2% +$18.9K 0.18% 115
2025
Q4 		$796K Sell
3,483
-1,463
-30% -$333K 0.18% 109
2025
Q3 		$800K Buy
4,946
+1,234
+33% +$251K 0.17% 109
2025
Q2 		$689K Buy
3,712
+23
+0.6% +$4.28K 0.17% 116
2025
Q1 		$771K Sell
3,689
-160
-4% -$31.1K 0.21% 101
2024
Q4 		$684K Buy
+3,849
New +$708K 0.17% 110

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PKS Advisory Services's ABBV Position: Q1 2026 in Review

PKS Advisory Services increased its AbbVie (ABBV) stake by 2.4% in Q1 2026, buying an estimated $18.9K and bringing the position to 3,568 shares worth $775K. The position accounts for 0.18% of the portfolio, ranked #115.

PKS Advisory Services first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $800K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • PKS Advisory Services held 3,568 shares of AbbVie worth $775K as of Q1 2026.
  • PKS Advisory Services bought 85 AbbVie shares in Q1 2026, an estimated $18.9K.
  • AbbVie made up 0.18% of PKS Advisory Services's portfolio in Q1 2026, its #115 holding.
  • PKS Advisory Services first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • PKS Advisory Services's AbbVie position peaked at $800K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on PKS Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.